Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP7374 vs Egg-derived TIV in Elderly
NCT01767896Phase 3Completed
- Sponsor
- UMN Pharma Inc.
- Start
- Oct 2012
- Primary completion
- Mar 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of ASP7374 in influenza, sponsored by UMN Pharma Inc.. Started Oct 2012; status: completed.
02
Drugs
ASP7374
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01767896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01767896.